RecruitingPhase 2Phase 3NCT06223828

Azithromycin for Critical Asthma - Pediatrics

Azithromycin as Immunomodulation Among Children Hospitalized for Critical Asthma: A Prospective, Open-Label, Non-Randomized, Interventional Study With Parallel Biospecimen Banking


Sponsor

Johns Hopkins All Children's Hospital

Enrollment

100 participants

Start Date

Apr 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The CR-AZI Study will assess the immunomodulatory effects of Azithromycin for pediatric Critical Asthma.


Eligibility

Min Age: 3 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an antibiotic called azithromycin, given early to children admitted to the intensive care unit (ICU) with a severe asthma attack, can shorten the length of their hospital stay and reduce the severity of the attack. **You may be eligible if...** - You are between 3 and 17 years old - You have been admitted to a pediatric ICU (PICU) with a primary diagnosis of severe asthma - You are receiving continuous inhaled or intravenous medications to open the airways (beta-agonist therapy) - You are receiving IV corticosteroids (steroids given through a drip) **You may NOT be eligible if...** - You have unrepaired congenital heart disease - You have a tracheostomy - You are already taking azithromycin or a similar antibiotic (macrolide) - You have a known history of long QT syndrome or heart arrhythmias - You have another lung condition such as cystic fibrosis, pulmonary hypertension, or sickle cell acute chest syndrome Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGAzithromycin

10mg/kg/dose (max dose 500mg) once daily for 3 days


Locations(1)

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06223828


Related Trials